Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
1.015
-0.005 (-0.52%)
Nov 21, 2024, 3:18 PM EST - Market open
Adial Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 7 | 2 | 6 | 57 | 24 | 25 | |
| Market Cap Growth | 89.00% | -60.76% | -89.79% | 131.14% | -1.60% | -27.71% | |
| Enterprise Value | 1 | 2 | 0 | 50 | 17 | 16 | |
| Last Close Price | 1.02 | 1.86 | 5.38 | 67.50 | 42.50 | 60.25 | |
| PB Ratio | 0.29 | 0.55 | 1.76 | 16.12 | 6.14 | 3.48 | |
| P/TBV Ratio | 1.09 | 0.56 | 1.76 | 20.21 | 6.15 | 3.49 | |
| Debt / Equity Ratio | - | - | - | 0.07 | - | - | |
| Quick Ratio | 6.28 | 4.33 | 2.23 | 2.23 | 2.92 | 12.57 | |
| Current Ratio | 6.78 | 4.90 | 2.67 | 2.37 | 3.41 | 14.24 | |
| Return on Equity (ROE) | -316.95% | -190.27% | -318.27% | -518.38% | -195.80% | -148.36% | |
| Return on Assets (ROA) | -106.05% | -82.24% | -102.78% | -170.58% | -103.71% | -83.26% | |
| Return on Capital (ROIC) | -123.55% | -116.98% | -192.78% | -285.36% | -122.77% | -88.98% | |
| Earnings Yield | -199.68% | -226.15% | -220.51% | -34.34% | -44.52% | -34.55% | |
| FCF Yield | -102.41% | -300.46% | -193.74% | -21.24% | -31.20% | -25.49% | |
| Buyback Yield / Dilution | -248.35% | -42.25% | -34.69% | -49.15% | -26.50% | -107.01% | |
| Total Shareholder Return | -248.35% | -42.25% | -34.69% | -49.15% | -26.50% | -107.01% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.